Clinical trial
The Correlation Research Between the Omega-3 and Omega-6 Inflammatory Metabolites and Stable COPD.
NCT04042519 is registered in ClinicalTrials.gov with Guangzhou Institute of Respiratory Disease as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Correlation Research Between the Omega-3 and Omega-6 Inflammatory Metabolites and Stable COPD.
- Lead sponsor
- Guangzhou Institute of Respiratory Disease
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2016
- Completion date
- July 5, 2019
- Enrollment
- 200 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
copd, metabolomics, omega 3, omega 6